产品名称 | NebuSelect™ Recombinant Human NKG2A&CD94, mFc-tag |
---|---|
目录号 | NBL-240842 |
别名 | NKG2A&CD94; CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94 |
外观 | see COA |
分子量 | Arg100-Leu233(NKG2A) & Ser34-Ile179(CD94) |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P26715-1(NKG2A)&Q13241-1(CD94) |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240842-100ug | 100ug | Inquire | Inquire | |
NBL-240842-1mg | 1mg | Inquire | Inquire | |
NBL-240842-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human NKG2A&CD94, mFc-tag
Catalog#:
NBL-240842
Description:
NebuSelect™ Recombinant Human NKG2A&CD94, mFc-tag(Cat#NBL-240842) is expressed in HEK293 with mFc (IgG1) tag at the C-Terminus.It contains Arg100-Leu233(NKG2A)&Ser34-Ile179(CD94).
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 56.9 kDa. Due to glycosylation, the protein migrates to 70-90 kDa based on Bis-Tris PAGE result.
Target Name:
NKG2A&CD94; CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94
Target Information:
The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.
Amino Acid Sequence:
Arg100-Leu233(NKG2A) & Ser34-Ile179(CD94)
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.